Pharming Group N.V. Royalty Expense
Pharming Group N.V. (PHAR) reported Royalty Expense of $5.79 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:RoyaltyExpense · last filed 2026-04-02
| Period end | Royalty Expense 12 month |
|---|---|
| 2025-12-31 | $5.79M 20-F · filed 2026-04-02 |
| 2024-12-31 | $4.91M 20-F · filed 2026-04-02 |
| 2023-12-31 | $2.15M 20-F · filed 2026-04-02 |
| 2022-12-31 | $0.00 20-F · filed 2025-04-03 |
| 2021-12-31 | $0.00 20-F · filed 2024-04-04 |